(Q44269708)

1 December 2017

title

P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma (English)

1 reference

1 December 2017

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Takeshi Terashima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Eishiro Mizukoshi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kuniaki Arai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Tatsuya Yamashita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mariko Yoshida

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hajime Ota

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Masato Kayahara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Koushiro Ohtsubo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Takashi Kagaya

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Masao Honda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Shuichi Kaneko

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

16 March 2014

1 reference

Cancer Immunology, Immunotherapy

1 December 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

479-489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-014-1529-8

10 June 2020

exact match

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Potential targets for pancreatic cancer immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1529-8

10.1007/S00262-014-1529-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633336%20AND%20SRC:MED&resulttype=core&format=json

release_p7s2t5hyg5dkrou5uwmihdl2mi

10 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p7s2t5hyg5dkrou5uwmihdl2mi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference